Chung Jane

Chung Jane is listed in filings as Chief Executive Officer at Sutro Biopharma, Inc.. This profile follows SEC Form 4 activity through Mar 6, 2026, including purchase activity. Recent filings connect the profile to Sutro Biopharma, Inc. (STRO) and Viracta Therapeutics, Inc. (VIRX). The current snapshot covers public activity from Jun 24, 2024 to Mar 6, 2026. Reported amounts are shown as $6.0K to $57.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.